News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3 Yael L. Maxwell May 17, 2024
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News EuroPCR 2023 Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast Shelley Wood May 16, 2023
News Conference News EuroPCR 2022 JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use Caitlin E. Cox May 18, 2022
News Conference News EuroPCR 2020 ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead Yael L. Maxwell July 03, 2020
News Conference News EuroPCR 2019 Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation L.A. McKeown June 06, 2019
News Conference News EuroPCR 2019 New Clarity on Patients at High Risk for Bleeding After PCI Michael O'Riordan May 28, 2019
News Conference News EuroPCR 2017 DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting Yael L. Maxwell May 22, 2017
News Conference News EuroPCR 2017 Transradial PCI in ACS Reduces Risk of Acute Kidney Injury Michael O'Riordan May 18, 2017
News Conference News EuroPCR 2016 ‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR Yael L. Maxwell May 18, 2016
News Conference News EuroPCR 2015 Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days Yael L. Maxwell May 21, 2015
News Conference News EuroPCR 2014 EuroPCR Features PAD Therapies in Early Development and Real-World Use Caitlin E. Cox May 21, 2014
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome Caitlin E. Cox May 18, 2012